← Leaderboards
Jeffrey T. Jensen
Oregon Health And Science University
$6,862,852
Attributed
$8,713,899
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $754.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,713,899 · 13
By mechanism
R01$5,034,598 · 2
U54$2,756,548 · 1
P51$615,975 · 9
R43$306,778 · 1
Top collaborators
- Kim A. Woodrow5 shared
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Richard L Stouffer$23,398,962
- Diane M Duffy$7,086,831
- Kelly Ansley Young$958,216
- Mary B. Zelinski$13,620,706
- Jon D Hennebold$17,405,346
Others in their field
Top investigators on “Macaca Mulatta”
- Barton F Haynes · Duke University$291,595,855
- Peter Gordon Gillespie · Oregon Health And Science University$83,402,374
- Richard A Gibbs · Baylor College Of Medicine$82,928,769
- Dan H. Barouch · Fred Hutchinson Cancer Center$67,567,747
- David I Watkins · George Washington University$57,087,952
- Rama Rao Amara · Emory University$54,145,017
Research focus
Macaca MulattaPreventPregnancyContraceptive AgentsContraceptive MethodsPrimatesWomanUnintended PregnancyIn VivoMacacaOvulationAffectPeriodicityPartner In RelationshipFemaleOocyte MaturationFertilizationInhibitor/AntagonistCellsBaseAdverse EffectsPhosphoric Diester HydrolaseClinical TrialsGenerations
Grant awards (28)
A simple device for office evaluation of tubal patency during the workup for infertility.$306,778
R43 · FY2025 · HD · contact PI
A low-profile copper intrauterine device that delivers long-acting contraception an$733,984
R01 · FY2024 · AI
A low-profile copper intrauterine device that delivers long-acting contraception an$739,742
R01 · FY2023 · AI
A low-profile copper intrauterine device that delivers long-acting contraception an$725,143
R01 · FY2022 · AI
A low-profile copper intrauterine device that delivers long-acting contraception an$754,528
R01 · FY2021 · AI
A low-profile copper intrauterine device that delivers long-acting contraception an$748,698
R01 · FY2020 · AI
Control of Oocyte Maturation$344,750
U54 · FY2016 · HD · contact PI
Control of Oocyte Maturation$344,750
U54 · FY2015 · HD · contact PI
Control of Oocyte Maturation$335,097
U54 · FY2014 · HD · contact PI
Control of Oocyte Maturation$327,168
U54 · FY2013 · HD · contact PI
Control of Oocyte Maturation$344,750
U54 · FY2012 · HD · contact PI
Control of Oocyte Maturation$352,570
U54 · FY2011 · HD · contact PI
TRANSCERVICAL POLIDOCANOL FOAM AS NONSURGICAL FEMALE STERILIZATION TECHNIQUE$58,239
P51 · FY2011 · RR · contact PI
PHOSPHODIESTERASE 3 INHIBITORS: BLOCKERS OF OOCYTE MATURATION AND FERTILIZATION$36,286
P51 · FY2011 · RR · contact PI
Control of Oocyte Maturation$238,827
U54 · FY2010 · HD · contact PI
PHOSPHODIESTERASE 3 INHIBITORS: BLOCKERS OF OOCYTE MATURATION AND FERTILIZATION$76,080
P51 · FY2010 · RR · contact PI
Control of Oocyte Maturation$236,547
U54 · FY2009 · HD · contact PI
PHOSPHODIESTERASE 3 INHIBITORS: BLOCKERS OF OOCYTE MATURATION AND FERTILIZATION$80,343
P51 · FY2009 · RR · contact PI
Control of Oocyte Maturation$232,089
U54 · FY2008 · HD · contact PI
PHOSPHODIESTERASE 3 INHIBITORS: BLOCKERS OF OOCYTE MATURATION AND FERTILIZATION$55,512
P51 · FY2008 · RR · contact PI
PDE3 Inhibitors: Selective Blockers of Oocyte Maturation$339,211
R01 · FY2007 · HD · contact PI
PHOSPHODIESTERASE 3 INHIBITORS: BLOCKERS OF OOCYTE MATURATION AND FERTILIZATION$75,850
P51 · FY2007 · RR · contact PI
PDE3 Inhibitors: Selective Blockers of Oocyte Maturation$349,342
R01 · FY2006 · HD · contact PI
PHOSPHODIESTERASE 3 INHIBITORS: SELECTIVE BLOCKERS OF OOCYTE MATURATION AND FERT$76,828
P51 · FY2006 · RR · contact PI
PDE3 Inhibitors: Selective Blockers of Oocyte Maturation$321,975
R01 · FY2005 · HD
PHOSPHODIESTERASE 3 INHIBITORS: SELECTIVE BLOCKERS OF OOCYTE MATURATION AND FERT$74,664
P51 · FY2005 · RR
PDE3 Inhibitors: Selective Blockers of Oocyte Maturation$321,975
R01 · FY2004 · HD
TRANSCERVICAL POLIDOCANOL AS A NON-SURGICAL METHOD OF FEMALE STERILIZATION$82,173
P51 · FY2004 · RR